Author(s)

Cecile Ingrid Djuikoue^1*, Paule Dana Djouela Djoulako², Rodrigue Kamga Wouambo³, Charlène Nkouankou Tomi¹, Christiane Possi Kiyang¹, Murielle Chantale Tchitchoua¹, Vynnie Manuella Nyatchoutou¹, Blondelle Kitio Messeu¹, Herman Koyouo Tagne¹, Cedric Dylan Seugnou Nana¹, Nadjia Benhamed⁴, Hortense Gonsu Kamga⁵, Benjamin D. Thumamo Pokam⁶

¹Faculty of Health Sciences, Université des Montagnes, Bangangté, Cameroon.
²Faculty of Medicine, Sorbonne Université, Paris, France.
³Division of Hepatology, Department of Medecine II, Leipzig University Medical Center, Leipzig, Germany.
⁴University of Sciences and Technology, Oran, Algeria.
⁵Bacteriology Unit, University Teaching Hospital, Yaounde, Cameroon.
⁶Department of Medical Laboratory Science, Faculty of Health Sciences, University of Buea, Buea, Cameroon.

Background: Carbapenemase-producing Enterobacteriaceae (CPE) are an important and increasing threat to global health. They are nowadays more encountered routinely in hospitals and cause high morbidity and mortality due to limited therapeutic alternatives. This study sought to determine the prevalence of CPE in Yaoundé teaching hospital, Cameroon, and the associated risk factors. Materials and Method: To achieve this goal, a descriptive cross-sectional study coupled to an analytical component with consecutive collection of Enterobacteria strains was carried out during a three-month period (from 27^th July to 24^th October 2018) in the University Teaching Hospital of Yaoundé, Cameroon. The oxidase and biochemical identification tests using a miniaturized Api 20 E system were performed on colonies grown on Eosin Methylene Blue (EMB) medium and subcultured on nutrient agar. Drug susceptibility testing was carried out according to the Antibiogram Committee of the French Society of Microbiology (CA-SFM 2018.V.2.0). The detection of carbapenemase production was performed by the CA-SFM 2018 algorithm for the screening of carbapenemase-producing enterobacteriaceae and its classification by inhibitory synergy tests. Results: Out of the 104 isolates, Escherichia coli (50%) was the most prevalent species, followed by Klebsiella pneumoniae (37.5%) and Citrobacter frendii (12.5%). Drugs susceptibility patterns showed a high resistance to penicillins group (97.4% to amoxicillin), cephalosporins (68.4% to cefotaxim, 58.1% to cefixim, 60.7% to ceftazidim, 57.1% of cefoxitin) and aztreonam (55.7%). However, 11.9% carbapenems related resistance was noticed: 14.4% to imipenem, 13.8% to ertapenem and 7.5% to meropenem. Numerous co-resistance to quinolones (65.8%), fluoroquinolones (49.6%), aminoglycosides (49.6%) and cotrimoxazole (71.8%) were also observed. From 104 isolates, AmpC production represented 23.08% (25/104) and 36.54% (38/104) were ESBL-isolates. The overall prevalence of CPE was 25% (26/104) with K.pneumoniae predominant (61.53%). Besides, Class A and class B carbapenemase were mainly produced with respectively 20% (21/104) and 5% (5/104). Univariate analysis revealed a significant association of carbapenemase production to Klebsiella pneumoniae (p = 0.01), ESBL and AmpC production ((P = 0.01 and P = 0.001 respectively) while that association was only significant to Klebsiella spp (p = 0.04) and AmpC production (p = 0.02) in multivariate analysis. Conclusion: The multi-resistance of Enterobacteriaceae to antibiotics in Cameroon has considerably increased. More attention should be paid to those bacteria to stall antimicrobial resistance spread.

Enterobacteriaceae, Antibiotics, Carbapenemase, Resistance

Djuikoue, C. , Djoulako, P. , Wouambo, R. , Tomi, C. , Kiyang, C. , Tchitchoua, M. , Nyatchoutou, V. , Messeu, B. , Tagne, H. , Nana, C. , Benhamed, N. , Kamga, H. and Pokam, B. (2023) Phenotypic Characterization of Carbapenemase-Producing Enterobacteriaceae Strains in a Referral Teaching Hospital in Yaoundé, Cameroon. Open Journal of Medical Microbiology, 13, 52-67. doi: 10.4236/ojmm.2023.131005.